在癌症研究中整合数字病理学,蛋白质组学,临床数据和人工智能分析的观点
Jéssica Guedes1, Nicole Woldmar1, A Marcell Szasz2
1Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
Journal of proteomics
|July 18, 2025
概括
整合数字病理学,分子分析和人工智能增强了癌症研究. 这种方法有助于生物标志物发现和患者分层,以提高精确的瘤学结果.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 数字病理学数字病理学
背景情况:
- 癌症影响近40%的个体,对免疫治疗的持续反应有限,治疗成本高.
- 目前的治疗进展面临的挑战是患者分层和预测治疗反应.
- 数字病理学,分子分析和计算策略的融合为癌症研究提供了变革性的潜力.
研究的目的:
- 审查新兴技术整合数字病理学,分子分析和AI用于癌症研究.
- 探索这些综合方法如何加速生物标志物发现和完善患者分层.
- 用一个黑色素瘤病例研究来说明这些原则的应用.
主要方法:
- 审查新兴技术,包括人工智能驱动的图像分析和深度视觉蛋白质组学.
- 整合高分辨率的形态数据与蛋白质学,转录学和空间分子见解.
- 黑色素瘤的案例研究利用数字病理学和深度蛋白质组分析.
主要成果:
- 展示了人工智能驱动分析的潜力,以整合形态,临床和分子数据.
- 发现了一种分子特征,可以预测早期黑色素瘤的复发.
- 强调了综合方法提供多维视图的瘤生物学的能力.
结论:
- 数字病理学,空间蛋白质组学和人工智能驱动分析的整合为了解瘤生物学提供了一个全面的框架.
- 这种方法有助于发现疾病复发和治疗反应的强大的生物标志物.
- 精确瘤学可以通过人工智能支持的整合各种患者数据来定制治疗策略来推进.
关键词:
在这里,我们可以看到AIAIAI.癌症生物标志物 癌症生物标志物深度视觉蛋白质组学数字病理学数字病理学激光捕捉微解剖是指激光捕捉的微解剖.机器学习是机器学习.黑色素瘤是一种黑色素瘤.患者的分层是患者的分层.蛋白质组学是指蛋白质组学.空间蛋白质组学是什么意思瘤微环境是一个微环境.更多相关视频
08:05Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
670
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
3.9K
相关概念视频
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K